Recent studies have demonstrated that, besides its antiviral function, RIG-I plays a role in other cellular processes: RIG-I deficiency in mice induces progressive myeloproliferative disorder, enhances leukemic stemness, and promotes hepatocellular carcinogenesis [5, 9, 10]. Here, RIGI is linked to myeloproliferative disorder.